8/25/2021 7:01:27 AM
CTI BioPharma And DRI Healthcare Trust Announce Up To $135 Mln Debt And Royalty Transaction
8/24/2021 7:02:27 AM
CTI BioPharma Appoints Diane Parks To Board
8/5/2021 4:09:06 PM
CTI BioPharma Q2 Loss/share $0.21 Vs. Loss $0.19 Year Ago
7/9/2021 12:52:32 AM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6/1/2021 4:15:12 PM
CTI BioPharma Q1 Loss/share $0.23 Vs. Loss $0.20 Year Ago
3/31/2021 11:53:24 PM
CTI BioPharma Announces Pricing Of Public Offering Of Common Stock And Preferred Stock
3/31/2021 7:04:14 AM
CTI BioPharma Completes Rolling Submission Of NDA For Pacritinib In Myelofibrosis Patients With Severe Thrombocytopenia
3/22/2021 10:03:16 AM
CTI : Phase 1 Trial Shows Promising Safety Profile Of Pacritinib For Prevention Of Graft-Versus-Host Disease
3/17/2021 4:10:57 PM
CTI BioPharma Q4 Loss/share $0.20 Vs. Loss $0.14 Year Ago